Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
Oh totally agree with car culture. Walkable cities are fantastic. But again, it’s not like cities were more walkable in the 60’s, 70’s, and 80’s. Hell, if anything, cities have become MORE walkable in recent decades than they were back then.